
Medpace Holdings, Inc.
Medpace Holdings, Inc. (MEDP) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · MEDP · as of Jun 8, 2026
Key Statistics
Explore Medpace Holdings, Inc. Data
medp stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 19 · Buy rate: 31.6%
The MEDP analyst consensus is Hold, based on ratings from 19 Wall Street analysts over the past 3 months. The average 12-month price target is $498.86, representing +9.82% upside from the current price of $454.25.
Competitors & Peers
medp competitorsStock Performance
Full HistoryAbout Medpace Holdings, Inc.
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical developme…
what is medpace holdings, inc. · medp stock overview · medpace holdings, inc. company profile · who is medpace holdings, inc. ceo · medp NASDAQ · medpace holdings, inc. headquarters · medpace holdings, inc. business segments
About Stock Overview & Key Data
Medpace Holdings, Inc. (MEDP) is a Healthcare company in the Medical - Diagnostics & Research industry, listed on NASDAQ since Aug 11, 2016. As of the latest trading session, MEDP stock price is $454.25, with a market capitalization of $13.0B. The stock has returned +52.27% over the past 12 months and -19.12% year-to-date.
According to 19 Wall Street analysts, the consensus rating for Medpace Holdings, Inc. stock is Hold, with an average 12-month price target of $498.86. In fiscal year 2025, Medpace Holdings, Inc. reported revenue of $2.5B and net income of $451.1M. For detailed data — including Medpace Holdings, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Medpace Holdings, Inc. (MEDP) stock price is $454.25. The stock is traded on NASDAQ under the ticker symbol MEDP. The 52-week range is $293.20 – $628.92.